Applied DNA Signs New Contract with U.S. Defense Logistics Agency
May 5th, 2021
Applied DNA Signs New Contract with U.S. Defense Logistics Agency
May 5th, 2021
APDN Secures Amendment to MSA and 4th Blanket Purchase Order
April 26th, 2021
APDN Provides Preliminary Estimated FQ2’21 Revenue Range and Business Update
April 21st, 2021
APDN, Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial
April 12th, 2021
Applied DNA CEO Discusses Relevance of DNA-based Cotton Traceability as Enabler of Ethical and Responsible Textile Manufacturing on BBC Business Daily
April 8th, 2021
APDN, Northwell Health Establish SARS-CoV-2 Mutation and Variant Tracking Program
April 7th, 2021
APDN Appoints Clay Shorrock as Chief Legal Officer and Executive Director of Business Development
April 1st, 2021
APDN Receives Purchase Order for 10,000 Linea™ COVID-19 Assay Kits
March 11th, 2021
Linea™ COVID-19 Selective Genomic Surveillance™ Mutation Panel
March 9th, 2021

Our new ticker symbol is ‘BNBX’. Learn more here.